| Trial ID: | L0631 |
| Source ID: | TCTR20140303003
|
| Associated Drug: |
Curcumin
|
| Title: |
Efficacy and mechanism of curcumin in prevention and treatment of diabetes, liver cirrhosis from nonalcoholic fatty liver disease (NAFLD), and osteoporosis in the patients with type 2 diabetes
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
curcuminoids extract
type 2 diabetes
insulin resistance
obesity
fatty liver
osteoporosis
<br>curcuminoids extract<br>type 2 diabetes<br>insulin resistance<br>obesity<br>fatty liver<br>osteoporosis<br>;curcuminoids extract<br>type 2 diabetes<br>insu
|
| Interventions: |
Starch component,Curcuminoids component;Placebo Comparator Drug,Active Comparator Drug;Control,Active (Curcumin)
|
| Outcome Measures: |
Evaluate in the metabolic components, obesity, fatty liver and osteoporosis 1 year t-testInflammatory markers and oxidative stress 1 year t-test
|
| Sponsor/Collaborators: |
National Research Council of Thailand (NRCT)
|
| Gender: |
All
|
| Age: |
25 Years65 Years
|
| Phases: |
Phase 3
|
| Enrollment: |
296
|
| Study Type: |
Interventional
|
| Study Designs: |
Randomized
|
| Start Date: |
03/03/2014
|
| Completion Date: |
31/12/2015
|
| Results First Posted: |
--
|
| Last Update Posted: |
7 February 2022
|
| Locations: |
Thailand
|
| URL: |
www.thaiclinicaltrials.org/show/TCTR20140303003
|
